Adriamycin
- Product NDC
- 0143-9275
- 11-digit product format
- 001439275
- Labeler code
- 0143
- Product ID
- 0143-9275_79560e42-fedf-48d0-b2f9-db8b1feacf0b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA062921
- Marketing category
- ANDA
- Marketing start
- 2018-01-19
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0143-9275-01 | Adriamycin | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | | 7 |
| 0143-9275-01 | Adriamycin | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0143-9275 | ADRIAMYCIN (DOXORUBICIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 7 | Legacy NDC, 2 package rows | 20240413_090bc1b1-3dc2-408d-94e6-48d2a3d4426c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0143-9275-01 | 00143927501 | 1 VIAL in 1 BOX (0143-9275-01) > 5 mL in 1 VIAL | 1 vial | 2018-01-19 | 0000-00-00 | No | No | Current |